Security key
48115J109
Journey Medical Corp - Common Stock SH (DERM)
CUSIP: 48115J109
Q3 2022 13F Holders as of 30 Sep 2022
- Security type / class
- Equity / Common Stock SH
- Total 13F shares
- 1,878,524
- Total 13F value
- $4,621,000
- Share change
- +134,093
- SEC-reported price per share
- $2.46
- Number of holders
- 18
- Value change
- +$328,580
- Number of buys
- 10
- Number of sells
- 4
- Shares outstanding
- 22,265,936
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
18
Top holders
10
DERM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Journey Medical Corp SEC filings
Journey Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 48115J109
Recent filing periods:
Ownership snapshot
Top reported holders of DERM - Journey Medical Corp - Common Stock SH (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Fortress Biotech, Inc.
Disclosed value leader
Fortress Biotech, Inc.
Comparable rows
0/13
Latest evidence
30 Jun 2022
3/4/5
13F
Highest disclosed value: $11,735,820
13 rows are not safely comparable across share classes.
Showing 1-6 of 13 holder rows.
Quick read
Fortress Biotech, Inc. has the largest disclosed position value at $11.74M.
0 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Fortress Biotech, Inc.'s linked filing trail.
Disclosed position value
Top 5
Fortress Biotech, Inc.
$11.74M
BRC Group Holdings, Inc.
$3.23M
Opaleye Management Inc.
$919K
PERKINS CAPITAL MANAGEMENT INC
$823K
Neuberger Berman Group LLC
$737K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$11,735,820
3,860,467 shares
|
— | 12 May 2022 |
| BRC Group Holdings, Inc. |
13F
Company
|
—
denominator unverified
|
$3,234,000
864,695 shares
|
— | 30 Jun 2022 |
| Opaleye Management Inc. |
13F
Company
|
—
denominator unverified
|
$919,000
245,733 shares
|
— | 30 Jun 2022 |
| PERKINS CAPITAL MANAGEMENT INC |
13F
Company
|
—
denominator unverified
|
$823,000
220,050 shares
|
— | 30 Jun 2022 |
| Neuberger Berman Group LLC |
13F
Company
|
—
denominator unverified
|
$737,000
197,137 shares
|
— | 30 Jun 2022 |
| AMERICAN FINANCIAL GROUP INC |
13F
Company
|
—
denominator unverified
|
$673,000
180,000 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
1,878,524
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q4 2025 Across Filers
Q4 2025 holders
76
Q3 2022 holders
18
Holder diff
-58
| Investor | Q4 2025 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q4 2025 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend